Global Sofosbuvir Market Research Report 2022

Publisher Name :
Date: 24-Jun-2022
No. of pages: 90
Inquire Before Buying

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2017 to 2028. by Application segment also provides consumption during the forecast period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Purity = 98%

- Purity < 98%

Segment by Application

- Adults Patients

- Elderly Patients

By Company

- Teva Pharmaceutical Industries Ltd

- DONG BANG FUTURE TECH & LIFE CO., LTD

- Beaukev Pharma International Pvt.Ltd

- DEAFARMA

- Tecoland

- Anhui HaiKang Pharmaceutical Co. Ltd

- Shanghai Haoyuan Chemexpress Co., Ltd

- Beijing Kawin Technology Share-holding Co

- Hangzhou Longshine Bio-Tech Co

Production by Region

- North America

- Europe

- China

- Japan

Consumption by Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

Global Sofosbuvir Market Research Report 2022

Table of Contents
1 Sofosbuvir Market Overview
1.1 Product Overview and Scope of Sofosbuvir
1.2 Sofosbuvir Segment by Type
1.2.1 Global Sofosbuvir Market Size Growth Rate Analysis by Type 2022 VS 2028
1.2.2 Purity ? 98%
1.2.3 Purity ? 98%
1.3 Sofosbuvir Segment by Application
1.3.1 Global Sofosbuvir Consumption Comparison by Application: 2022 VS 2028
1.3.2 Adults Patients
1.3.3 Elderly Patients
1.4 Global Market Growth Prospects
1.4.1 Global Sofosbuvir Revenue Estimates and Forecasts (2017-2028)
1.4.2 Global Sofosbuvir Production Capacity Estimates and Forecasts (2017-2028)
1.4.3 Global Sofosbuvir Production Estimates and Forecasts (2017-2028)
1.5 Global Market Size by Region
1.5.1 Global Sofosbuvir Market Size Estimates and Forecasts by Region: 2017 VS 2021 VS 2028
1.5.2 North America Sofosbuvir Estimates and Forecasts (2017-2028)
1.5.3 Europe Sofosbuvir Estimates and Forecasts (2017-2028)
1.5.4 China Sofosbuvir Estimates and Forecasts (2017-2028)
1.5.5 Japan Sofosbuvir Estimates and Forecasts (2017-2028)
2 Market Competition by Manufacturers
2.1 Global Sofosbuvir Production Capacity Market Share by Manufacturers (2017-2022)
2.2 Global Sofosbuvir Revenue Market Share by Manufacturers (2017-2022)
2.3 Sofosbuvir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Sofosbuvir Average Price by Manufacturers (2017-2022)
2.5 Manufacturers Sofosbuvir Production Sites, Area Served, Product Types
2.6 Sofosbuvir Market Competitive Situation and Trends
2.6.1 Sofosbuvir Market Concentration Rate
2.6.2 Global 5 and 10 Largest Sofosbuvir Players Market Share by Revenue
2.6.3 Mergers & Acquisitions, Expansion
3 Production Capacity by Region
3.1 Global Production Capacity of Sofosbuvir Market Share by Region (2017-2022)
3.2 Global Sofosbuvir Revenue Market Share by Region (2017-2022)
3.3 Global Sofosbuvir Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.4 North America Sofosbuvir Production
3.4.1 North America Sofosbuvir Production Growth Rate (2017-2022)
3.4.2 North America Sofosbuvir Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.5 Europe Sofosbuvir Production
3.5.1 Europe Sofosbuvir Production Growth Rate (2017-2022)
3.5.2 Europe Sofosbuvir Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.6 China Sofosbuvir Production
3.6.1 China Sofosbuvir Production Growth Rate (2017-2022)
3.6.2 China Sofosbuvir Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.7 Japan Sofosbuvir Production
3.7.1 Japan Sofosbuvir Production Growth Rate (2017-2022)
3.7.2 Japan Sofosbuvir Production Capacity, Revenue, Price and Gross Margin (2017-2022)
4 Global Sofosbuvir Consumption by Region
4.1 Global Sofosbuvir Consumption by Region
4.1.1 Global Sofosbuvir Consumption by Region
4.1.2 Global Sofosbuvir Consumption Market Share by Region
4.2 North America
4.2.1 North America Sofosbuvir Consumption by Country
4.2.2 U.S.
4.2.3 Canada
4.3 Europe
4.3.1 Europe Sofosbuvir Consumption by Country
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific Sofosbuvir Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 China Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America Sofosbuvir Consumption by Country
4.5.2 Mexico
4.5.3 Brazil
5 Segment by Type
5.1 Global Sofosbuvir Production Market Share by Type (2017-2022)
5.2 Global Sofosbuvir Revenue Market Share by Type (2017-2022)
5.3 Global Sofosbuvir Price by Type (2017-2022)
6 Segment by Application
6.1 Global Sofosbuvir Production Market Share by Application (2017-2022)
6.2 Global Sofosbuvir Revenue Market Share by Application (2017-2022)
6.3 Global Sofosbuvir Price by Application (2017-2022)
7 Key Companies Profiled
7.1 Teva Pharmaceutical Industries Ltd
7.1.1 Teva Pharmaceutical Industries Ltd Sofosbuvir Corporation Information
7.1.2 Teva Pharmaceutical Industries Ltd Sofosbuvir Product Portfolio
7.1.3 Teva Pharmaceutical Industries Ltd Sofosbuvir Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.1.4 Teva Pharmaceutical Industries Ltd Main Business and Markets Served
7.1.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.2 DONG BANG FUTURE TECH & LIFE CO., LTD
7.2.1 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir Corporation Information
7.2.2 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir Product Portfolio
7.2.3 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.2.4 DONG BANG FUTURE TECH & LIFE CO., LTD Main Business and Markets Served
7.2.5 DONG BANG FUTURE TECH & LIFE CO., LTD Recent Developments/Updates
7.3 Beaukev Pharma International Pvt.Ltd
7.3.1 Beaukev Pharma International Pvt.Ltd Sofosbuvir Corporation Information
7.3.2 Beaukev Pharma International Pvt.Ltd Sofosbuvir Product Portfolio
7.3.3 Beaukev Pharma International Pvt.Ltd Sofosbuvir Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.3.4 Beaukev Pharma International Pvt.Ltd Main Business and Markets Served
7.3.5 Beaukev Pharma International Pvt.Ltd Recent Developments/Updates
7.4 DEAFARMA
7.4.1 DEAFARMA Sofosbuvir Corporation Information
7.4.2 DEAFARMA Sofosbuvir Product Portfolio
7.4.3 DEAFARMA Sofosbuvir Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.4.4 DEAFARMA Main Business and Markets Served
7.4.5 DEAFARMA Recent Developments/Updates
7.5 Tecoland
7.5.1 Tecoland Sofosbuvir Corporation Information
7.5.2 Tecoland Sofosbuvir Product Portfolio
7.5.3 Tecoland Sofosbuvir Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.5.4 Tecoland Main Business and Markets Served
7.5.5 Tecoland Recent Developments/Updates
7.6 Anhui HaiKang Pharmaceutical Co. Ltd
7.6.1 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir Corporation Information
7.6.2 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir Product Portfolio
7.6.3 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.6.4 Anhui HaiKang Pharmaceutical Co. Ltd Main Business and Markets Served
7.6.5 Anhui HaiKang Pharmaceutical Co. Ltd Recent Developments/Updates
7.7 Shanghai Haoyuan Chemexpress Co., Ltd
7.7.1 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir Corporation Information
7.7.2 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir Product Portfolio
7.7.3 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.7.4 Shanghai Haoyuan Chemexpress Co., Ltd Main Business and Markets Served
7.7.5 Shanghai Haoyuan Chemexpress Co., Ltd Recent Developments/Updates
7.8 Beijing Kawin Technology Share-holding Co
7.8.1 Beijing Kawin Technology Share-holding Co Sofosbuvir Corporation Information
7.8.2 Beijing Kawin Technology Share-holding Co Sofosbuvir Product Portfolio
7.8.3 Beijing Kawin Technology Share-holding Co Sofosbuvir Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.8.4 Beijing Kawin Technology Share-holding Co Main Business and Markets Served
7.7.5 Beijing Kawin Technology Share-holding Co Recent Developments/Updates
7.9 Hangzhou Longshine Bio-Tech Co
7.9.1 Hangzhou Longshine Bio-Tech Co Sofosbuvir Corporation Information
7.9.2 Hangzhou Longshine Bio-Tech Co Sofosbuvir Product Portfolio
7.9.3 Hangzhou Longshine Bio-Tech Co Sofosbuvir Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.9.4 Hangzhou Longshine Bio-Tech Co Main Business and Markets Served
7.9.5 Hangzhou Longshine Bio-Tech Co Recent Developments/Updates
8 Sofosbuvir Manufacturing Cost Analysis
8.1 Sofosbuvir Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Sofosbuvir
8.4 Sofosbuvir Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Sofosbuvir Distributors List
9.3 Sofosbuvir Customers
10 Market Dynamics
10.1 Sofosbuvir Industry Trends
10.2 Sofosbuvir Market Drivers
10.3 Sofosbuvir Market Challenges
10.4 Sofosbuvir Market Restraints
11 Production and Supply Forecast
11.1 Global Forecasted Production of Sofosbuvir by Region (2023-2028)
11.2 North America Sofosbuvir Production, Revenue Forecast (2023-2028)
11.3 Europe Sofosbuvir Production, Revenue Forecast (2023-2028)
11.4 China Sofosbuvir Production, Revenue Forecast (2023-2028)
11.5 Japan Sofosbuvir Production, Revenue Forecast (2023-2028)
12 Consumption and Demand Forecast
12.1 Global Forecasted Demand Analysis of Sofosbuvir
12.2 North America Forecasted Consumption of Sofosbuvir by Country
12.3 Europe Market Forecasted Consumption of Sofosbuvir by Country
12.4 Asia Pacific Market Forecasted Consumption of Sofosbuvir by Region
12.5 Latin America Forecasted Consumption of Sofosbuvir by Country
13 Forecast by Type and by Application (2023-2028)
13.1 Global Production, Revenue and Price Forecast by Type (2023-2028)
13.1.1 Global Forecasted Production of Sofosbuvir by Type (2023-2028)
13.1.2 Global Forecasted Revenue of Sofosbuvir by Type (2023-2028)
13.1.3 Global Forecasted Price of Sofosbuvir by Type (2023-2028)
13.2 Global Forecasted Consumption of Sofosbuvir by Application (2023-2028)
13.2.1 Global Forecasted Production of Sofosbuvir by Application (2023-2028)
13.2.2 Global Forecasted Revenue of Sofosbuvir by Application (2023-2028)
13.2.3 Global Forecasted Price of Sofosbuvir by Application (2023-2028)
14 Research Finding and Conclusion
15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer
List of Tables
Table 1. Global Sofosbuvir Market Size by Type (MT) & (US$ Million) (2022 VS 2028)
Table 2. Global Sofosbuvir Market Size by Application (MT) & (US$ Million) (2022 VS 2028)
Table 3. Sofosbuvir Market Size Comparison by Region: 2017 VS 2021 VS 2028
Table 4. Global Sofosbuvir Production Capacity by Manufacturers (2017-2022) & (MT)
Table 5. Global Sofosbuvir Production (MT) by Manufacturers (2017-2022)
Table 6. Global Sofosbuvir Production Market Share by Manufacturers (2017-2022)
Table 7. Global Sofosbuvir Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 8. Global Sofosbuvir Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sofosbuvir as of 2021)
Table 10. Global Market Sofosbuvir Average Price (USD/MT) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Sofosbuvir Production Sites and Area Served
Table 12. Manufacturers Sofosbuvir Product Types
Table 13. Global Sofosbuvir Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Sofosbuvir Production Capacity (MT) by Region (2017-2022)
Table 16. Global Sofosbuvir Production (MT) by Region (2017-2022)
Table 17. Global Sofosbuvir Revenue (US$ Million) by Region (2017-2022)
Table 18. Global Sofosbuvir Revenue Market Share by Region (2017-2022)
Table 19. Global Sofosbuvir Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 20. North America Sofosbuvir Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 21. Europe Sofosbuvir Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 22. China Sofosbuvir Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 23. Japan Sofosbuvir Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 24. Global Sofosbuvir Consumption Market by Region (2017-2022) & (MT)
Table 25. Global Sofosbuvir Consumption Market Share by Region (2017-2022)
Table 26. North America Sofosbuvir Consumption by Country (2017-2022) & (MT)
Table 27. Europe Sofosbuvir Consumption by Country (2017-2022) & (MT)
Table 28. Asia Pacific Sofosbuvir Consumption by Region (2017-2022) & (MT)
Table 29. Latin America Sofosbuvir Consumption by Country (2017-2022) & (MT)
Table 30. Global Sofosbuvir Production (MT) by Type (2017-2022)
Table 31. Global Sofosbuvir Production Market Share by Type (2017-2022)
Table 32. Global Sofosbuvir Revenue (US$ Million) by Type (2017-2022)
Table 33. Global Sofosbuvir Revenue Share by Type (2017-2022)
Table 34. Global Sofosbuvir Price (USD/MT) by Type (2017-2022)
Table 35. Global Sofosbuvir Production by Application (2017-2022) & (MT)
Table 36. Global Sofosbuvir Production Market Share by Application (2017-2022)
Table 37. Global Sofosbuvir Revenue (US$ Million) by Application (2017-2022)
Table 38. Global Sofosbuvir Revenue Share by Application (2017-2022)
Table 39. Global Sofosbuvir Price (USD/MT) by Application (2017-2022)
Table 40. Teva Pharmaceutical Industries Ltd Sofosbuvir Corporation Information
Table 41. Teva Pharmaceutical Industries Ltd Specification and Application
Table 42. Teva Pharmaceutical Industries Ltd Sofosbuvir Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 43. Teva Pharmaceutical Industries Ltd Main Business and Markets Served
Table 44. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 45. DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir Corporation Information
Table 46. DONG BANG FUTURE TECH & LIFE CO., LTD Specification and Application
Table 47. DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 48. DONG BANG FUTURE TECH & LIFE CO., LTD Main Business and Markets Served
Table 49. DONG BANG FUTURE TECH & LIFE CO., LTD Recent Developments/Updates
Table 50. Beaukev Pharma International Pvt.Ltd Sofosbuvir Corporation Information
Table 51. Beaukev Pharma International Pvt.Ltd Specification and Application
Table 52. Beaukev Pharma International Pvt.Ltd Sofosbuvir Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 53. Beaukev Pharma International Pvt.Ltd Main Business and Markets Served
Table 54. Beaukev Pharma International Pvt.Ltd Recent Developments/Updates
Table 55. DEAFARMA Sofosbuvir Corporation Information
Table 56. DEAFARMA Specification and Application
Table 57. DEAFARMA Sofosbuvir Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 58. DEAFARMA Main Business and Markets Served
Table 59. DEAFARMA Recent Developments/Updates
Table 60. Tecoland Sofosbuvir Corporation Information
Table 61. Tecoland Specification and Application
Table 62. Tecoland Sofosbuvir Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 63. Tecoland Main Business and Markets Served
Table 64. Tecoland Recent Developments/Updates
Table 65. Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir Corporation Information
Table 66. Anhui HaiKang Pharmaceutical Co. Ltd Specification and Application
Table 67. Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 68. Anhui HaiKang Pharmaceutical Co. Ltd Main Business and Markets Served
Table 69. Anhui HaiKang Pharmaceutical Co. Ltd Recent Developments/Updates
Table 70. Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir Corporation Information
Table 71. Shanghai Haoyuan Chemexpress Co., Ltd Specification and Application
Table 72. Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 73. Shanghai Haoyuan Chemexpress Co., Ltd Main Business and Markets Served
Table 74. Shanghai Haoyuan Chemexpress Co., Ltd Recent Developments/Updates
Table 75. Beijing Kawin Technology Share-holding Co Sofosbuvir Corporation Information
Table 76. Beijing Kawin Technology Share-holding Co Specification and Application
Table 77. Beijing Kawin Technology Share-holding Co Sofosbuvir Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 78. Beijing Kawin Technology Share-holding Co Main Business and Markets Served
Table 79. Beijing Kawin Technology Share-holding Co Recent Developments/Updates
Table 80. Hangzhou Longshine Bio-Tech Co Sofosbuvir Corporation Information
Table 81. Hangzhou Longshine Bio-Tech Co Specification and Application
Table 82. Hangzhou Longshine Bio-Tech Co Sofosbuvir Production Capacity (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 83. Hangzhou Longshine Bio-Tech Co Main Business and Markets Served
Table 84. Hangzhou Longshine Bio-Tech Co Recent Developments/Updates
Table 85. Production Base and Market Concentration Rate of Raw Material
Table 86. Key Suppliers of Raw Materials
Table 87. Sofosbuvir Distributors List
Table 88. Sofosbuvir Customers List
Table 89. Sofosbuvir Market Trends
Table 90. Sofosbuvir Market Drivers
Table 91. Sofosbuvir Market Challenges
Table 92. Sofosbuvir Market Restraints
Table 93. Global Sofosbuvir Production (MT) Forecast by Region (2023-2028)
Table 94. North America Sofosbuvir Consumption Forecast by Country (2023-2028) & (MT)
Table 95. Europe Sofosbuvir Consumption Forecast by Country (2023-2028) & (MT)
Table 96. Asia Pacific Sofosbuvir Consumption Forecast by Region (2023-2028) & (MT)
Table 97. Latin America Sofosbuvir Consumption Forecast by Country (2023-2028) & (MT)
Table 98. Global Sofosbuvir Production Forecast by Type (2023-2028) & (MT)
Table 99. Global Sofosbuvir Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 100. Global Sofosbuvir Price Forecast by Type (2023-2028) & (USD/MT)
Table 101. Global Sofosbuvir Production Forecast by Application (2023-2028) & (MT)
Table 102. Global Sofosbuvir Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 103. Global Sofosbuvir Price Forecast by Application (2023-2028) & (USD/MT)
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Sofosbuvir
Figure 2. Global Sofosbuvir Market Share by Type: 2022 VS 2028
Figure 3. Purity ? 98% Product Picture
Figure 4. Purity ? 98% Product Picture
Figure 5. Global Sofosbuvir Market Share by Application: 2022 VS 2028
Figure 6. Adults Patients
Figure 7. Elderly Patients
Figure 8. Global Sofosbuvir Revenue (US$ Million), 2017 VS 2021 VS 2028
Figure 9. Global Sofosbuvir Revenue (US$ Million) (2017-2028)
Figure 10. Global Sofosbuvir Production Capacity (MT) & (2017-2028)
Figure 11. Global Sofosbuvir Production (MT) & (2017-2028)
Figure 12. North America Sofosbuvir Revenue (US$ Million) and Growth Rate (2017-2028)
Figure 13. Europe Sofosbuvir Revenue (US$ Million) and Growth Rate (2017-2028)
Figure 14. China Sofosbuvir Revenue (US$ Million) and Growth Rate (2017-2028)
Figure 15. Japan Sofosbuvir Revenue (US$ Million) and Growth Rate (2017-2028)
Figure 16. Sofosbuvir Production Share by Manufacturers in 2021
Figure 17. Global Sofosbuvir Revenue Share by Manufacturers in 2021
Figure 18. Sofosbuvir Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 19. Global Market Sofosbuvir Average Price (USD/MT) of Key Manufacturers in 2021
Figure 20. The Global 5 and 10 Largest Players: Market Share by Sofosbuvir Revenue in 2021
Figure 21. Global Sofosbuvir Production Market Share by Region (2017-2022)
Figure 22. North America Sofosbuvir Production (MT) Growth Rate (2017-2022)
Figure 23. Europe Sofosbuvir Production (MT) Growth Rate (2017-2022)
Figure 24. China Sofosbuvir Production (MT) Growth Rate (2017-2022)
Figure 25. Japan Sofosbuvir Production (MT) Growth Rate (2017-2022)
Figure 26. Global Sofosbuvir Consumption Market Share by Region (2017-2022)
Figure 27. North America Sofosbuvir Consumption and Growth Rate (2017-2022) & (MT)
Figure 28. North America Sofosbuvir Consumption Market Share by Country in 2021
Figure 29. Canada Sofosbuvir Consumption Growth Rate (2017-2022) & (MT)
Figure 30. U.S. Sofosbuvir Consumption Growth Rate (2017-2022) & (MT)
Figure 31. Europe Sofosbuvir Consumption Growth Rate (2017-2022) & (MT)
Figure 32. Europe Sofosbuvir Consumption Market Share by Country in 2021
Figure 33. Germany Sofosbuvir Consumption and Growth Rate (2017-2022) & (MT)
Figure 34. France Sofosbuvir Consumption and Growth Rate (2017-2022) & (MT)
Figure 35. U.K. Sofosbuvir Consumption and Growth Rate (2017-2022) & (MT)
Figure 36. Italy Sofosbuvir Consumption and Growth Rate (2017-2022) & (MT)
Figure 37. Russia Sofosbuvir Consumption and Growth Rate (2017-2022) & (MT)
Figure 38. Asia Pacific Sofosbuvir Consumption and Growth Rate (2017-2022) & (MT)
Figure 39. Asia Pacific Sofosbuvir Consumption Market Share by Regions in 2021
Figure 40. China Sofosbuvir Consumption and Growth Rate (2017-2022) & (MT)
Figure 41. Japan Sofosbuvir Consumption and Growth Rate (2017-2022) & (MT)
Figure 42. South Korea Sofosbuvir Consumption and Growth Rate (2017-2022) & (MT)
Figure 43. China Taiwan Sofosbuvir Consumption and Growth Rate (2017-2022) & (MT)
Figure 44. Southeast Asia Sofosbuvir Consumption and Growth Rate (2017-2022) & (MT)
Figure 45. India Sofosbuvir Consumption and Growth Rate (2017-2022) & (MT)
Figure 46. Australia Sofosbuvir Consumption and Growth Rate (2017-2022) & (MT)
Figure 47. Latin America Sofosbuvir Consumption and Growth Rate (2017-2022) & (MT)
Figure 48. Latin America Sofosbuvir Consumption Market Share by Country in 2021
Figure 49. Mexico Sofosbuvir Consumption and Growth Rate (2017-2022) & (MT)
Figure 50. Brazil Sofosbuvir Consumption and Growth Rate (2017-2022) & (MT)
Figure 51. Production Market Share of Sofosbuvir by Type (2017-2022)
Figure 52. Production Market Share of Sofosbuvir by Type in 2021
Figure 53. Revenue Share of Sofosbuvir by Type (2017-2022)
Figure 54. Revenue Market Share of Sofosbuvir by Type in 2021
Figure 55. Production Market Share of Sofosbuvir by Application (2017-2022)
Figure 56. Production Market Share of Sofosbuvir by Application in 2021
Figure 57. Revenue Share of Sofosbuvir by Application (2017-2022)
Figure 58. Revenue Market Share of Sofosbuvir by Application in 2021
Figure 59. Manufacturing Cost Structure of Sofosbuvir
Figure 60. Manufacturing Process Analysis of Sofosbuvir
Figure 61. Sofosbuvir Industrial Chain Analysis
Figure 62. Channels of Distribution
Figure 63. Distributors Profiles
Figure 64. Global Sofosbuvir Production Market Share Forecast by Region (2023-2028)
Figure 65. North America Sofosbuvir Production (MT) Growth Rate Forecast (2023-2028)
Figure 66. Europe Sofosbuvir Production (MT) Growth Rate Forecast (2023-2028)
Figure 67. China Sofosbuvir Production (MT) Growth Rate Forecast (2023-2028)
Figure 68. Japan Sofosbuvir Production (MT) Growth Rate Forecast (2023-2028)
Figure 69. Global Forecasted Demand Analysis of Sofosbuvir (2017-2028) & (MT)
Figure 70. Global Sofosbuvir Production Market Share Forecast by Type (2023-2028)
Figure 71. Global Sofosbuvir Revenue Market Share Forecast by Type (2023-2028)
Figure 72. Global Sofosbuvir Production Market Share Forecast by Application (2023-2028)
Figure 73. Global Sofosbuvir Revenue Market Share Forecast by Application (2023-2028)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
  • Global Hepatitis A Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 89
    According to our LPI (LP Information) latest study, the global Hepatitis A Vaccine market size was valued at US$ 690.5 million in 2023. With growing demand in downstream market, the Hepatitis A Vaccine is forecast to a readjusted size of US$ 810.9 million by 2030 with a CAGR of 2.3% during review period. The research report highlights the growth potential of the global Hepatitis A Vaccine market. Hepatitis A Vaccine are expected to show stable growth in the future market. However, produc......
  • Global Human Hepatitis B Immunoglobulin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 127
    Market Overview of Global Human Hepatitis B Immunoglobulin market: According to our latest research, the global Human Hepatitis B Immunoglobulin market looks promising in the next 5 years. As of 2022, the global Human Hepatitis B Immunoglobulin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensiv......
  • Global Hepatitis A Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 85
    According to our (Global Info Research) latest study, the global Hepatitis A Vaccine market size was valued at USD 726.3 million in 2023 and is forecast to a readjusted size of USD 842.5 million by 2030 with a CAGR of 2.1% during review period. Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currentl......
  • Global Hepatitis A Vaccine Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117
    Report Overview: Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 ye......
  • Global Thymosin a1 Professional Survey Report 2023, Forecast to 2028
    Published: 15-Nov-2023        Price: US 3280 Onwards        Pages: 103
    Thymosin ?? is a peptide fragment derived from prothymosin alpha, a protein that in humans is encoded by the PTMA gene. It was the first of the peptides from Thymosin Fraction 5 to be completely sequenced and synthesized. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their ......
  • Global Thymosin a1 Market Research Report 2023, Forecast to 2028
    Published: 15-Nov-2023        Price: US 2680 Onwards        Pages: 136
    Thymosin ?? is a peptide fragment derived from prothymosin alpha, a protein that in humans is encoded by the PTMA gene. It was the first of the peptides from Thymosin Fraction 5 to be completely sequenced and synthesized. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their ......
  • Global Hepatitis B Immune Globulin Market Research Report 2023
    Published: 06-Nov-2023        Price: US 2900 Onwards        Pages: 85
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Hepatitis B Immune Globulin market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - ADMA Biologics - Bio Products Laboratory - Grifols - Biotest AG - CSL Behring - FFF Enterprises - Cleveland Clinic Seg......
  • Global Sofosbuvir Market Research Report 2023
    Published: 31-Oct-2023        Price: US 2900 Onwards        Pages: 94
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sofosbuvir market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Teva Pharmaceutical Industries Ltd - DONG BANG FUTURE TECH & LIFE CO., LTD - Beaukev Pharma International Pvt.Ltd - DEAFARMA - Tecoland - Anhui HaiKang Pha......
  • Global Hepatitis A Vaccine Market Insights, Forecast to 2029
    Published: 22-Sep-2023        Price: US 4900 Onwards        Pages: 97
    Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs